Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2019 047 958.1 |
96 | EP file number | EAKZ | 19 84 2049.9 |
86 | WO file number | WAKZ | PCT/US2019/042827 |
97 | EP publication number | EPN | 3823617 |
87 | WO publication number | WPN | 2020023391 |
54 | Designation/title | TI | ENANTIOMERENREINER GP-AGONIST ZUR VERWENDUNG BEI DER BEHANDLUNG VON KRANKHEITSZUSTÄNDEN UND ERKRANKUNGEN |
51 | IPC main class | ICM (ICMV) | C07D 405/04 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07C 309/19 (2006.01), C07C 309/29 (2006.01), C07C 309/35 (2006.01), A61P 35/00 (2006.01), A61K 31/47 (2006.01) |
22 | DE application date | DAT | Jul 22, 2019 |
96 | EP application date | EAT | Jul 22, 2019 |
86 | WO application date | WAT | Jul 22, 2019 |
43 | Date of first publication | OT | Jan 30, 2020 |
| Date of publication of grant | PET | Mar 6, 2024 |
71/73 | Applicant/owner | INH | Linnaeus Therapeutics, Inc., Haddonfield, NJ, US |
72 | Inventor | IN | NATALE, Christopher, Philadelphia, Pennsylvania 19146, US; MOONEY, Patrick, Haddonfield, New Jersey 08033, US; GARYANTES, Tina, Warren, New Jersey 07059, US; LUKE, Wayne, Lafayette, Indiana 47906, US |
| Address for service | | RWS Group, Translation Division, CHALFONT ST PETER, Bucks SL9 9FG, GB |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201862701726 P Jul 21, 2018
|
| Due date | FT FG | Jul 31, 2025 Annual fee for the 7th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003823617A1 Searchable text:
EP000003823617A1 Original document:
EP000003823617B1 Searchable text:
EP000003823617B1 Original document:
WO002020023391 Searchable text:
WO002020023391 |
43 | Date of first publication | EVT | Jan 30, 2020 |
| Date of the first transfer into DPMAregister | EREGT | May 26, 2021 |
| Date of the (most recent) update in DPMAregister | REGT | Feb 27, 2025 (Show all update days)(Hide all update days)- Feb 27, 2025
- Procedures: Procedure relating to EP application, Grant has become final, 09.12.2024: changed
- Jan 23, 2025
- Procedures: Procedure relating to EP application, Grant has become final, 09.12.2024: new
- Aug 7, 2024
- St.36: changed (technical change)
- Jun 28, 2024; Jun 8, 2024; Jun 6, 2024; Mar 21, 2024; Feb 15, 2024; Oct 5, 2023
- Historical data not available for this/these date(s)
- May 26, 2021
- Date of the first transfer into DPMAregister
|